Minneapolis, MN, United States
IntegraDose Compounding Services LLC recalls
7 recalls recorded since 2018, most recently on 18 May 2026. 6 are listed as ongoing. Status and classification are as published by the FDA.
Recalls7
Ongoing (FDA)6
Terminated or completed1
Class I (FDA)1
Ongoing Class II Drugs
- Recall started
- 18 May 2026
- Reason
- Subpotent Drug
- Distribution
- U.S.A. Nationwide
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0593-2026
- Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.
Ongoing Class II Drugs
- Recall started
- 12 May 2026
- Reason
- Subpotent Drug
- Distribution
- Nationwide.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0548-2026
- fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.
Ongoing Class I Drugs
- Recall started
- 16 September 2025
- Reason
- Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
- Distribution
- Nationwide in the USA
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0015-2026
- Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1
Ongoing Class II Drugs
- Recall started
- 22 March 2024
- Reason
- Lack of Assurance of Sterility: leaking bags
- Distribution
- Nationwide within the U.S
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0432-2024
- fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-6030-1
Ongoing Class II Drugs
- Recall started
- 22 January 2024
- Reason
- Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
- Distribution
- MN
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0325-2024
- Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71
Ongoing Class II Drugs
- Recall started
- 12 January 2024
- Reason
- Subpotent Drug
- Distribution
- MN only
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0258-2024
- Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1
Terminated Class II Drugs
- Recall started
- 17 September 2021
- Terminated
- 2 October 2022
- Reason
- Lack of sterility assurance.
- Distribution
- NH, MA, MN
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0896-2021, D-0897-2021
- ceFAZolin, 2 G/20 mL in Sterile Water, 20 mL Sterile Syringe for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-7087-1
- ceFAZolin 3 G in 0.9% Sodium Chloride, 115 mL Bag for Injection, Sterile Product, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC: 71139-7153-1
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.